Cefditoren pivoxil

Cefditoren

Clinical data
Trade names	Spectracef
AHFS/Drugs.com	Monograph
MedlinePlus	a605003
ATC code	J01DD16 (WHO)
Identifiers
IUPAC name (7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((Z)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Number	104145-95-1 N
PubChem CID	9870843
DrugBank	DB01066 Y
ChemSpider	8046534 Y
UNII	81QS09V3YW
KEGG	D07639 N
ChEBI	CHEBI:59343 Y
ChEMBL	CHEMBL610374 N
ECHA InfoCard	100.214.754
Chemical and physical data
Formula	C19H18N6O5S3
Molar mass	506.58 g/mol
3D model (JSmol)	Interactive image
SMILES O=C3N2/C(=C(/C=C\c1scnc1C)CS[C@@H]2[C@@H]3NC(=O)C(=N\OC)/c4nc(sc4)N)C(=O)O
InChI InChI=1S/C19H18N6O5S3/c1-8-11(33-7-21-8)4-3-9-5-31-17-13(16(27)25(17)14(9)18(28)29)23-15(26)12(24-30-2)10-6-32-19(20)22-10/h3-4,6-7,13,17H,5H2,1-2H3,(H2,20,22)(H,23,26)(H,28,29)/b4-3-,24-12-/t13-,17-/m1/s1 Y Key:KMIPKYQIOVAHOP-YLGJWRNMSA-N Y
NY (what is this?)

Cefditoren is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef by Vansen Pharma Inc.

Cefditoren is also marketed under the name Meiact by Meiji Seika Pharma Co., Ltd.

Cefditoren has a broad spectrum of activity and has been used to treat bacterial infections of the skin and respiratory tract, including bronchitis, pneumonia, and tonsillitis. The following represents MIC susceptibility data for a few medically significant microorganisms.

Cefditoren is a broad-spectrum antibiotic against Gram-negative and Gram-positive bacteria, but does not have antibacterial activity against Pseudomonas aeruginosa.

Cefditoren is used to treat uncomplicated skin and skin structure infections, community-acquired pneumonia, acute bacterial exacerbation of chronic bronchitis, pharyngitis, and tonsillitis.

Cefditoren is available as 200- and 400-mg tablets. It can be formulated as the prodrug cefditoren pivoxil.